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Renal phenotype is exacerbated in Os and lpr double mutant
mice.
Background. ROP-Os/+ mice are born with oligosyndactyly
and oligonephronia and develop renal dysfunction, which
includes renal tubular epithelial cell (RTC) Fas-dependent
apoptosis and tubular atrophy. MRL/lpr mice harbor a Fas-
inactivating mutation and develop glomerulonephritis, whereas
mice expressing lpr on a C3H background demonstrate no re-
nal phenotype. We hypothesized that crossing ROP-Os/+ with
CH3-lpr/lpr mice would rescue the Os/+ renal phenotype by
reducing Fas-dependent RTC apoptosis.
Methods. ROP-Os/+ mice were intercrossed with C3H-
lpr/lpr mice and F2 generation animals were phenotyped by
kidney weight, serum creatinine, and albuminuria. Kidney sec-
tions were scored for histopathology and apoptosis. Univariate
and multivariate analyses were used to examine additive effects
of Os and lpr on renal phenotype.
Results. By 16 weeks, F2 Os/+ lpr/lpr mice developed signif-
icantly more albuminuria, glomerulosclerosis, and interstitial
inflammation compared to Os/+ +/+ mice. Glomerular cell
apoptosis was increased in Os/+ lpr/lpr compared to Os/+ +/+
mice, with no significant difference in RTC apoptosis. A statis-
tically significant Os-lpr effect on renal phenotype was demon-
strated by multivariate analysis, which exceeded the combined
independent effects if Os and lpr, indicating a biologic interac-
tion exists between Os and lpr.
Conclusion. Os/+ mice with a superimposed lpr mutation dis-
played a more severe renal phenotype, rather than phenotype
rescue, suggesting that Fas pathway activation is necessary to
delete cells resulting from Os-dependent injury. We further pro-
pose that an Os-lpr gene interaction and/or mixed ROP-C3H
genetic background regulated the renal phenotype, consistent
with the concept that chronic renal disease pathogenesis reflects
effects of multiple nephropathy susceptibility alleles.
The Oligosyndactylism (Os) mutation was generated
in mice subjected to total body irradiation at Oak Ridge
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National Laboratory in 1953. Although detailed molecu-
lar characterization of the Os mutation is still lacking, we
have begun to analyze the renal transcriptome in these
mice [1]. Mapping studies indicate that the mutation(s)
involve at least suppressed recombination of a large chro-
mosome 8 segment and truncation of APC10 gene [2, 3].
Homozygous (Os/Os) mice die at the 64-cell stage be-
cause of mitotic arrest [4], whereas heterozygous (Os/+)
mice have impaired limb development that includes fused
digits of all extremities (oligosyndactyly) and a concomi-
tant renal phenotype characterized by oligonephronia
and small kidneys [5]. Whether Os/+ mice develop pro-
gressive renal disease is highly dependent on genetic
background. When the Os/+ mutation is expressed on a
sclerosis-prone ROP background, mice develop acceler-
ated azotemia, proteinuria, glomerulosclerosis, glomeru-
lar hypertrophy, and tubular atrophy [5–8]. However, sig-
nificant glomerular histopathology is not observed when
the mutation is bred into a C57BL/6 background (despite
similar nephron and glomerular cell numbers between
strains) [7, 8], indicating that background genes regulate
ROP-Os/+ renal phenotype.
In addition to severe glomerulosclerosis observed in
ROP-Os/+ mice, we have previously demonstrated that
there is also increased renal tubular epithelial cell (RTC)
apoptosis, which may contribute to tubular atrophy and
renal disease progression [9, 10]. The Fas (CD95, APO-1)
apoptosis receptor is up-regulated in RTC from ROP-
Os/+ compared to ROP+/+ mice at a time point that
precedes increased RTC apoptosis [9], suggesting that
RTC in ROP-Os/+ mice undergo Fas-dependent apop-
tosis. This possibility is supported by in vitro studies
demonstrating that Fas-expressing RTC are susceptible
to apoptosis following stimulation with agonistic Fas
antibodies [9–12].
One of the most definitive strategies to determine
pathogenetic roles for proteins is by selective inacti-
vation through genetic deletion or mutation, followed
by analysis of the consequent phenotype. A mouse
Fas-inactivating mutation [lpr (lymphoproliferative)] is
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well described and lpr mice have been exploited to
dissect the role of Fas-dependent apoptosis pathways
in kidney disease models [13, 14]. The lpr mutation
spontaneously arose following insertion of a 5.3 kb retro-
transposon between the third and fourth Fas exons [15,
16]. Homozygous lpr/lpr mice display marked lympho-
proliferation and splenomegaly, irrespective of genetic
background. MRL/lpr/lpr mice exhibit a fatal, autoim-
mune renal phenotype that resembles lupus nephritis,
whereas a homozygous lpr mutation in C3H and C57BL/6
mice show little evidence of glomerulonephritis [17].
Therefore, similar to Os/+ mice, genetic background is
also critical for development of the renal phenotype in
lpr/lpr mice.
The influence of genetic background was carefully
considered in designing a strategy to address the hy-
pothesis that RTC Fas regulates renal disease progres-
sion in ROP-Os/+ mice. Of the available lpr strains
(MRL/Mp, C57BL/6J and C3H/HeJ), C3H-lpr/lpr were
specifically chosen for breeding with ROP-Os/+ mice
because MRL/lpr/lpr display an Os-independent renal
phenotype that would confound analysis [17]. In addi-
tion, C57BL/6 mice harbor a relatively large number
of renal disease-modifying genes compared to C3H [18]
[abstract; Gharavi AG et al, J Am Soc Nephrol 10:404A,
1999], which conceivably could modulate Os-regulated
renal disease independent of lpr. Results from F2 inter-
crosses between ROP-Os/+ and C3H-lpr/lpr mice show
that instead of Fas inactivation rescuing the Os/+ renal
phenotype, Os/+ lpr/lpr mice surprisingly demonstrate
renal disease exacerbation.
METHODS
Mouse models
Female ROP-Os/+ and male C3H-lpr/lpr mice were
purchased from Jackson Laboratories (Bar Harbor, ME,
USA) and crossed to produce F1 generation mice. F1 mice
with Os/+ lpr/+ genotype were intercrossed by brother-
sister mating and the resulting F2 mice (N = 204) were
sacrificed for genotype and phenotype analyses at 4-week
intervals ranging from 4 to 32 weeks of age (Fig. 1). All
protocols were approved by the IACUC at Case Western
Reserve University.
Genotyping
The presence of oligosyndactyly, which was usually due
to fusion of the second and third toes, identified mice with
the Os/+ genotype. lpr genotyping was achieved by poly-
merase chain reaction (PCR) from genomic tail DNA
according to published methods [19] using three primers
(F1 GTAAATAATTGTGCTTCGTCAG, R1 TAGAA
AGGTGCACGGGTGTG, and R2 CAAATCTAGGC
ATTAACAGTG) for 1 minute at 94◦C, 45 seconds at
50◦C, 45 seconds at 74◦C for 30 cycles, and final exten-
sion for 7 minutes at 74◦C. The resulting wild-type Fas
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Fig. 1. Mice breeding strategy. F0 ROP Os/+ mice were crossed with
C3H lpr/lpr mice to generate F1 progeny that were heterozygous for
lpr. Half of the F1 mice were Os/+ and the other half +/+ at the Os
locus. F1 Os/+ lpr/+ mice were intercrossed by brother-sister mating to
produce six genotypes in the F2 generation.
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Fig. 2. Fas genotyping. Fas (wild-type) or lpr genotypes were deter-
mined by polymerase chain reaction (PCR) from genomic DNA using
three primers (F1 GTAAATAATTGTGCTTCGTCAG, R1 TAGAAA
GGTGCACGGGTGTG, R2 CAAATCTAGGCATTAACAGTG) for
1 minute at 94◦C, 45 seconds at 50◦C, 45 seconds at 74◦C for 30 cycles,
and final extension for 7 minutes at 74◦C. Fas allele PCR product is 212
bp, while Fas mutant lpr product is 184 bp.
PCR product is 184 bp, and the lpr product is 212 bp.
Results from a typical PCR reaction in mice with each
genotype are shown in Figure 2. Genotype notations are
presented for the Os allele first, followed by the Fas allele
(e.g., Os/+ lpr/+ mice are heterozygous at both alleles).
Phenotype analyses
Morphometry. Body weights were measured immedi-
ately prior to sacrifice, kidney weights were determined
immediately after organ harvesting, and kidney size is
expressed as the ratio of kidney:body weight.
Biochemical assays. Serum and urine creatinine were
measured using the colorimetric Infinity Creatinine
Assay (Sigma Diagnostic, St. Louis, MO, USA). Urine al-
bumin was measured using the Mouse Albumin enzyme-
linked immunosorbent assay (ELISA) Quantitation Kit
(Bethyl Lab, Montgomery, TX, USA). Creatinine and al-
bumin assay results are expressed in mg/dL.
Histology. Anesthetized mice were sacrificed by
exsanguination and kidneys were rapidly harvested, and
longitudinally sectioned. Formaldehyde-fixed kidney tis-
sues were imbedded in paraffin, sectioned, and stained
with periodic-Schiff (PAS) reagent by the MetroHealth
Medical Center Pathology Department. Histopathology
from a minimum of 50 40× fields per animal was in-
dependently scored on a 0 to 4 scale for severity of
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glomerulosclerosis, fibrocellular crescents, and tubuloin-
terstitial inflammatory infiltrates according to methods
modified from Mackay et al [20] by two investigators
blinded to mouse genotype. For glomerulosclerosis, 0 rep-
resented normal glomerulus, 1 was PAS-positive material
in >25% of glomerular area, but in <20% of glomeruli,
2 was 25% to 50% PAS-positive glomerular area in 20%
to 50% of glomeruli, 3 was >50% PAS-positive glomeru-
lar area in >50% of glomeruli, and 4 was mesangium in
all glomeruli contains PAS-positive material. For cres-
cents/synechiae, 0 was absence of crescents, 1 was oblit-
eration of Bowman’s space in <10% of glomeruli, 2 was
10% to 20% of glomeruli, 3 was 20% to 50% of glomeruli,
and 4 was >50% of glomeruli. For tubulointerstitial infil-
trates, 0 was absence of infiltrates, 1 was small mononu-
clear infiltrates (10 to 100 cells) between tubules and
involving two to four fields per section, 2 was small in-
filtrates involving > four fields per section or large infil-
trates (>100 cells) involving two to four fields per section,
3 was > four large infiltrates per section, but with pre-
served tubule architecture, and 4 was large infiltrates that
result in substantial obliteration of tubules. Total score is
derived by addition of scores for each genotype.
Apoptosis assays. Apoptotic nuclei were detected in
situ by TUNEL technique according to manufacturer in-
structions (Intergen, Purchase, NY, USA) and as pre-
viously described [9, 10]. Briefly, two to three frozen
kidney sections (from 32-week-old mice) were incu-
bated with terminal deoxynucleotidyl transferase (TdT)
and digoxigenin-labeled deoxyuridine triphosphate
(dUTP), followed by fluorescein isothiocyanate (FITC)-
conjugated antidigoxigenin IgG. All apoptotic cells were
counted in each section and classified according to
glomerular or tubular compartments. To normalize for
reduced nephron number and kidney size in Os/+ mice,
results are expressed as TUNEL-positive cells per
glomerulus and TUNEL-positive RTC per mm2 [surface
area was measured using Spot software (Diagnostic In-
struments, Sterling Heights, MI, USA)]. All observations
were made in a blinded fashion with respect to experi-
mental group.
Immunoblot analysis. Methods have previously been
described in detail [21]. Whole kidney lysates were
minced and boiled in 2× sodium dodecyl sulfate (SDS)
sample buffer (125 mmol/L Tris, pH 6.8, 2% SDS, 5%
glycerol, 1% b-mercaptoethanol, and 0.003% bromphe-
nol blue) and assayed for protein content (Bio-Rad,
Hercules, CA, USA). Samples were denatured by boil-
ing for 5 minutes, and 40 lg protein/lane was resolved
by 4% to 20% SDS-polyacrylamide gel electrophoresis
(PAGE) (Novex, San Diego, CA, USA). Proteins were
transferred to polyvinylidene difluoride (PVDF) mem-
branes, blocked with 5% nonfat milk, and incubated
with rabbit anti-Fas antibodies (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) (M20 clone, 1:1000, 2
hours, room temperature), followed by horseradish per-
oxidase (HRP)–conjugated antirabbit antibodies (Santa
Cruz Biotechnology) (1:5000, 1 hour, room temperature).
Protein bands were detected by enhanced chemilumines-
cence (ECL) (Amersham Pharmacia Biotech, Arlington
Heights, IL, USA).
Statistical analyses
Data are representative of two to four experiments
per condition. Results are expressed as mean ± SEM
unless otherwise indicated. Comparisons between geno-
type groups were made by one-way analysis of vari-
ance (ANOVA) with the Bonferroni or Kruskal-Wallis
tests for multiple comparisons of parametric and non-
parametric data, respectively. The effects of genotype
on level of protein excretion and histopathology score
were examined by univariate and multivariate analyses.
Univariate comparisons between genotype groups were
made by one-way ANOVA. Differences between multi-
ple group mean values (for lpr genotype) were confirmed
using Tukey’s test. Stepwise multivariate linear regres-
sion analyses were developed for each outcome. Main
effects of genotype and potential gene/gene interactions
were investigated. Statistical significance is defined as
P < 0.05.
RESULTS
F2 intercross outcomes
Four F0 founder pairs (ROP-Os/+ and C3H-lpr/lpr)
were mated to generate F1 mice, which were then inter-
crossed to produce F2 mice (N = 204) (Fig. 1). F2 gener-
ation mice revealed no significant deviation from antici-
pated Mendelian ratios at Os or Fas alleles [Os/+:+/+ =
1.9:1.0 (Os/Os is embryonic lethal); lpr/lpr:lpr/+:+/+ =
0.8:2.4:1.0], indicating that introduction of two muta-
tions (Os and lpr) was not lethal. Upon gross exam-
ination at time of sacrifice, there were no noticeable
anatomic abnormalities. One 28-week-old female mouse,
which was +/+ for Os and Fas alleles, was noted to
have unilateral hydronephrosis. All lpr/lpr mice exhibited
lymphadenopathy and splenomegaly, consistent with an
lpr/lpr lymphoproliferation phenotype observed on mul-
tiple genetic backgrounds [17].
Kidney and body weights
Body weights were not significantly different between
F2 genotypes prior to 20 weeks of age. Beyond 20 weeks,
Os/+ mice developed edema, although body weights did
not significantly differ between genotypes, presumably
due to concomitant muscle wasting. At all time points,
Os/+ kidneys (mean kidney:body weight ratio = 3.87
mg/g) were significantly smaller than +/+ kidneys
(mean = 6.76 mg/g), consistent with decreased nephron
number [5]. The lpr mutation had no effect on kid-
ney:body weight ratio (Fig. 3).
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Fig. 3. Kidney size according to genotype. Kidney weight/total body
weight (mg/g) ratios were calculated to determine the kidney mass in
mice aged 16 to 32 weeks (no statistically significant difference was
present before 16 weeks). ∗P < 0.05 by analysis of variance (ANOVA)
compared to kidney/body weight ratios from mice +/+ at the Os locus.
Renal function
One of the characteristic features of ROP-Os/+ mice
is albuminuria [5]. Differences in albuminuria between
genotypes were not observed up to 12 weeks of age (not
shown). By 16 weeks, significant increases in urine albu-
min excretion were noted in F2 Os/+ +/+ mice compared
to wild-type (+/+ +/+) controls (Fig. 4A), and this differ-
ence was maintained over time. Surprisingly, albuminuria
was even further increased in F2 double mutants (Os/+
lpr/lpr) and to intermediate levels in compound heterozy-
gotes (Os/+ lpr/+) (Fig. 4), suggesting that the lpr gene
may have a dose effect for renal dysfunction. Mean serum
creatinine values were not significantly different between
genotypes (data not shown), with values between 35 and
50 lmol/L, which is within the normal range for mice [22].
Kidney histopathology
In accordance with previous reports, Os/+ mice were
observed to have reduced number of glomeruli and
glomerular hypertrophy, regardless of lpr genotype
(Fig. 5). In mice younger than 16 weeks there was no sig-
nificant difference in the total or component histopathol-
ogy scores between genotypes. In general, lpr expres-
sion in mice which were +/+ at the Os locus (+/+ lpr/+,
+/+ lpr/lpr) demonstrated variable, but mild pathologic
changes (predominantly glomerulosclerosis) compared
to +/+ +/+ controls (Fig. 6), consistent with previous
reports [17]. Os/+ +/+ mice demonstrated histopatho-
logic differences compared to +/+ +/+ mice, includ-
ing glomerular hypertrophy, enhanced glomerular matrix
deposition, and thickened parietal epithelial cell layers,
consistent with published data [5]. Although Os/+ +/+
animals exhibited significant glomerular pathology, the
combined effect of Os/+ and lpr in F2 generation mice
resulted in exacerbation of the glomerular phenotype
(Figs. 5 and 6), including glomerular hypertrophy and
glomerulosclerosis, which is in agreement with the albu-
minuria data. Glomerular inflammation was not observed
in any animals. Os/+ lpr/lpr mice were noted to have a
four- to fivefold increase in interstitial inflammation com-
pared to Os/+ +/+ and Os/+ lpr/+ mice (Fig. 5C), though
tubular atrophy and interstitial fibrosis were minimal, and
not different between genotypes.
Glomerular and tubular epithelial cell apoptosis
To test whether the mechanism for exacerbated Os/+
phenotype in mice with superimposed lpr mutation could
be due to abrogation of beneficial, Fas-regulated apop-
tosis pathways [23, 24], apoptosis was assessed by the
TUNEL technique in 32-week-old mice. As shown in
Figure 7A, the number of apoptotic cells per glomeru-
lus was increased in Os/+ +/+ vs. +/+ +/+ mice, and
glomerular cell apoptosis was further increased in Os/+
lpr/lpr mice. Since lpr/lpr mice do not express Fas, in-
creased glomerular apoptosis is due to a Fas-independent
cell death mechanism. Optical resolution from the frozen
sections did not permit determination of whether resident
or invading cells were apoptotic. Consistent with our pre-
vious reports [9, 10] we observed increased tubular cell
apoptosis in Os/+ genotype compared to +/+ mice. The
lpr effect on tubular cell apoptosis was not statistically
significant (Fig. 7B).
Kidney Fas expression in F2 mice
One potential explanation for the worse phenotype in
Os/+ lpr/lpr mice is that the outbred genetic background
permitted improved Fas mRNA splicing, resulting in in-
creased Fas expression. To address this possibility, Fas
protein content was measured by immunoblot analysis
of whole kidney lysates from +/+ +/+, +/+ lpr/lpr, Os/+
+/+, and Os/+ lpr/lpr mice. Results of these experiments
showed that Fas expression was slightly increased in Os/+
+/+ compared to +/+ +/+ kidneys (Fig. 8), consistent
our previous reports [9, 10]. However, kidney Fas protein
was undetectable in +/+ lpr/lpr and Os/+ lpr/lpr groups,
suggesting that the mixed genetic background did not al-
ter Fas splicing or expression.
Modeling the specific Os-lpr genotype effects
on phenotype
By pooling data from all lpr genotypes and multiple
time points, a significant effect of Os genotype on al-
buminuria was evident (Os/+ = 23.5 ± 4.2 mg/dL vs.
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Fig. 4. Albuminuria according to genotype. (A) Albuminuria was measured by enzyme-linked immunosorbent assay (ELISA) and expressed in
mg/dL in mice with each genotype beginning at 16 weeks (no statistically significant difference was present before 16 weeks). Results are expressed
as mean albuminuria at 4-week interval time points. Error bars and statistical significance notations were omitted for clarity. Similar results were
observed when data were expressed as urine albumin:creatinine ratio (not shown). (B) Albuminuria data were pooled for time points from 16 to
32 weeks for each genotype. ∗P < 0.05 by analysis of variance (ANOVA) between Os/+ +/+ and the three groups +/+ at the Os locus.
Fig. 5. Renal histopathology according to genotype. Kidney paraffin
sections from 32-week-old mice were fixed and stained with periodic
acid-Schiff (PAS) as described in the Methods section. Representative
sections from each genotype are shown. (A) +/+ +/+, 40× magnifica-
tion. (B) Os/+ +/+, 40× magnification. (C) Os/+ lpr/lpr, 20× magnifi-
cation. (D) Os/+ lpr/lpr, 40× magnification. Arrows denote interstitial
infiltrates, arrowheads denote parietal epithelial thickening. ∗A severely
sclerotic glomerulus.
+/+ = 5.1 ± 0.8 mg/dL, P < 0.01). Similarly, the main
effects of lpr genotype on urine albumin excretion were
examined by combining Os/+ and +/+ genotypes and
stratifying according to lpr genotype, which showed pro-
gressive increases in levels of albuminuria according to lpr
status (+/+ = 7.8 ± 0.9 mg/dL, lpr/+ = 17.4 ± 4.1 mg/dL,
lpr/lpr = 26.4 ± 8.6 mg/dL). These group differences ap-
proached, but did not reach statistical significance (P =
0.12).
A similar procedure was performed to investigate
the effect of genotypes on histopathology scores and
glomerular apoptosis rates. For the Os genotype, univari-
ate analyses mirrored those of proteinuria, with Os geno-
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Fig. 6. Quantitative histolopathologic scores. Pathology scores from
32-week-old mice with each genotype were determined for glomeru-
losclerosis, crescents, interstitial infiltrates, and tubular atrophy by two
blinded investigators. Total score is the sum of individual scores. Data
are expressed as the mean score ± SE derived from the sum of all
pathological parameters. ∗P < 0.05 by analysis of variance (ANOVA)
compared to the three groups that are +/+ at the Os locus.
type associated with significantly worse pathology (Os/+
= 2.4 ± 0.2 vs. +/+ = 0.6 ± 0.1, P < 0.01) and apoptosis
(Os/+ = 0.15 ± 0.03 vs. +/+ = 0.04 ± 0.01, P < 0.01).
Differential effects were also detected according to lpr
status with lpr/lpr linked to the most severe renal pathol-
ogy (2.9 ± 0.5 compared to +/+ = 1.5 ± 0.2, P = 0.02)
and glomerular apoptosis (lpr/lpr = 0.12 ± 0.04 vs. +/+ =
0.07 ± 0.01), while lpr/+ genotype showed no effect
compared to wild-type for either renal phenotype (not
shown).
Multivariate analyses confirmed our univariate find-
ings, with an independent, statistically significant effect of
Os/+ on urine albumin excretion, histopathology score
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Fig. 7. Glomerular and tubular epithelial cell apoptosis according to
genotype. Apoptosis was determined by TUNEL technique. Frozen
sections were incubated with terminal deoxynucleotidyl transferase
(TdT) and digoxigenin-labeled deoxyuridine triphosphate (dUTP), fol-
lowed by peroxidase-conjugated antidigoxigenin antibody. Apoptotic
cells were counted by two blinded investigators. (A) Apoptotic cells
within glomeruli were counted and expressed as number of apoptotic
cells per glomerulus ± SE. (B) Apoptotic cells within the tubular com-
partment were counted and expressed as apoptotic cells per mm2.
∗P < 0.05 by analysis of variance (ANOVA) compared to +/+ +/+
and +/+ lpr/lpr groups. ∗∗P < 0.05 by ANOVA compared to all three
other groups.
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Fig. 8. Kidney Fas expression in F2 mice. Whole kidney lysates from
20-week-old, F2 generation mice with +/+ +/+, +/+ lpr/lpr, Os/+ +/+,
and Os/+ lpr/lpr genotypes were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (40 lg protein/lane).
Fas protein expression was detected by immunoblot analysis with anti-
Fas antibodies, and appears as a doublet at Mr = 45 kD [9].
and glomerular apoptosis. lpr/lpr mice showed a trend
toward significantly increased levels of albuminuria, and
the lpr mutation conferred an independent risk for ab-
normal histopathology and glomerular apoptosis. Finally,
we employed step-wise linear regression to evaluate an
additive statistical model to test for a dependent, bio-
logic interaction between Os and lpr on renal phenotype.
These analyses clearly showed more than an additive ef-
fect for the contribution of Os and lpr to albuminuria,
histopathology, and glomerular apoptosis (P < 0.01 for
Os/+ and P = 0.01 for lpr/lpr). The data indicate that risk
of renal disease in F2 Os/+ lpr/lpr mice exceeds the inde-
pendent effects of Os plus lpr, and is therefore evidence
for a biologic interaction between Os and lpr [25].
DISCUSSION
In previous studies, we demonstrated that Fas-
regulated RTC apoptosis was increased in ROP-Os/+
mice, suggesting that RTC Fas activation led to tubu-
lar atrophy [9, 10]. To address this possibility, we tested
whether the renal phenotype could be rescued by inter-
crossing ROP-Os/+ with Fas-deficient C3H-lpr/lpr mice.
Rather than observing an improved renal phenotype,
double mutant Os/+ lpr/lpr mice demonstrated greater
proteinuria and more extensive glomerular and tubuloin-
terstitial pathology compared to age-matched Os/+ +/+
counterparts.
Although the data do not support the hypothesis
that kidney cell Fas activation regulates tubular atro-
phy and renal disease progression in the ROP-Os/+
model, several factors may have confounded interpre-
tation of the results. The first possibility is that the hybrid
C3H/ROP background in F2 mice may be permissive for
Os-regulated renal disease, particularly since it is well es-
tablished that Os renal phenotypes are influenced by ge-
netic background [7]. ROP mice are now considered to be
an inbred strain, but the genetic background remains het-
erogeneous, comprised from a mixture of 101, C3H, and
C57BL/6 backgrounds [2]. Lenz et al [26] bred ROP-Os/+
with C3H mice, and F1 animals were then backcrossed to
ROP strain mice. The first backcrossed generation dis-
played a wide range of glomerular histopathology, but
the mean glomerulosclerosis score was less severe com-
pared to F0 ROP-Os/+ mice. Although this observation
could be interpreted in many ways, including that multi-
ple genes with variable penetrance contribute to the phe-
notype, another possibility is disease-dampening effect
of C3H modifier genes. We therefore anticipated that F2
Os/+ mice with combined ROP and C3H genetic back-
grounds might also exhibit less severe renal disease. Di-
rect comparison between F0 and F2 phenotypes was not
determined. However, urine albumin:creatinine ratios in
16-week-old to 32-week-old F2 Os/+ mice (not shown)
were comparable to levels observed in 40-week-old to
56-week-old Os/+ mice with pure ROP background [27],
suggesting that the C3H/ROP hybrid background pro-
motes renal phenotype development.
Since lpr mice develop renal disease on some, but
not all genetic backgrounds [17], an alternative expla-
nation for the exacerbated phenotype in F2 mice is
that lpr-regulated renal disease was unmasked in C3H
mice by introduction of the ROP background. In this
regard, increased mononuclear cell tubulointerstitial in-
filtrates were prominent in F2 lpr/lpr mice, consistent
with inadequate Fas-dependent, deletion of autoreactive
T cells, or other invading inflammatory cells, which may
be important for termination of fibrosis programs [23].
Alternatively, Fas activation can paradoxically mediate
cell proliferation following injury [24], suggesting that
Fas-regulated regeneration may have been impaired in
lpr/lpr mice, resulting in unabated proliferation of native
glomerular cells, which is an important mediator of kid-
ney disease [28].
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Statistical analyses demonstrated a greater than addi-
tive Os plus lpr effect on renal phenotype in F2 mice,
consistent with either a direct biologic interaction be-
tween Os and lpr or between genes that cosegregate
with Os and lpr. The gene(s) responsible for the Os re-
nal phenotype have not been identified, so it is difficult
to speculate about the molecular nature of the Os-lpr
interaction. Studies from the Striker laboratories show
that a variety of dissimilar insults, such as hyperglycemia,
subtotal nephrectomy, or estrogen deficiency manifest in
worse renal outcomes in ROP-Os/+ vs. ROP+/+ and in
ROP-Os/+ vs. C57BL/6-Os/+ mice [27, 29, 30]. Urine
albumin:creatinine ratios (mg/mg) in 16-week-old to 32-
week-old F2 mice (Os/+ +/+ = 0.16 ± 0.09 [SD] and
Os/+ lpr/lpr = 1.00 ± 0.43 [SD]) from our experiments
were comparable to levels observed in 10-month-old to
14-month-old Os/+ and ovariectomized Os/+ mice with
pure ROP background, respectively [27]. Although sta-
tistical tests to measure Os interaction were not reported,
observations by the same group that Os phenotypes may
be due to as many as 8 to 10 genetic loci [26] suggests
that multiple interactions with other disease genes may
regulate glomerular or tubulointerstitial renal disease
phenotypes.
CONCLUSION
Os/+ mice with a superimposed lpr mutation displayed
more severe glomerular and tubulointerstitial disease,
rather than phenotype rescue. We suggest that the pheno-
type arises from absent Fas-dependent deletion of injured
glomerular cells and/or Fas-independent glomerular cell
apoptosis. We further propose that the mixed ROP/C3H
genetic background may have unmasked susceptibility
factors that allowed Os and lpr gene interaction to pro-
duce a renal phenotype.
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